Stocks and Investing Stocks and Investing
Mon, March 1, 2021

Kevin DeGeeter Initiated (SNSE) at Buy and Held Target at $36 on, Mar 1st, 2021


Published on 2024-10-27 15:48:15 - WOPRAI, Kevin DeGeeter
  Print publication without navigation


Kevin DeGeeter of Oppenheimer, Initiated "Sensei Biotherapeutics, Inc." (SNSE) at Buy and Held Target at $36 on, Mar 1st, 2021.

Kevin, nor any peers, have made any analyst calls on SNSE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources